Sign in Create account

Vasundhara Rasayans Ltd.

Healthcare · Pharmaceuticals & Biotechnology

BSE: 538634
₹149.00
▼ -0.85 (-0.57%)
Sept. 30, 2026 · BSE · bse_bhavcopy
Quality
58/100
Moderate
Valuation
99/100
Undervalued
Momentum
46/100
Neutral

QVM read Cheap on its own multiples Quality Moderate, Valuation Undervalued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹47 Cr
PE (TTM)
8.0
Industry median 36.1 (152 companies)
Price to Book
1.2
PEG (TTM)
0.2
Institutions holding %
Data unavailable.
Piotroski Score
Data unavailable.
Relative return vs Nifty50, qtr %
Data unavailable.
Relative return vs Sector, qtr %
-50.0
Free Cash Flow
₹-2 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
13.33%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
35.60%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
3.84%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
13.09%
as of June 30, 2026
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
-8.33%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
6.87
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.04
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
26.31
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
9.35%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
13.33%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
23.60%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
12.17%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
20.03%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
14.26%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 7 met
  • No Net profit is higher than a year earlier in each of the last 4 quarters
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Debt to equity is below 0.5 (0.04)
  • No Return on equity is 15% or more (14.3%)
  • No Net cash flow for the latest year is positive
  • Yes Cash from operations is higher than the year before

Ownership

2 of 2 met
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • Yes Promoter pledge is 5% of their holding or less and not rising (0.0% pledged)

Peer comparison

0 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • No Profit growth beats the industry median

Value and momentum

2 of 6 met
  • Yes Price sits in the Buy zone of its own historical PE range (Undervalued (below its own historical PE range))
  • Yes Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • No Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs SENSEX)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-0.6%
Low 148.3500 · High 157.5000
1W return
-7.4%
Low 144.0000 · High 160.0000
1M return
-4.5%
Low 143.0500 · High 164.9500
52W return
-50.0%
Low 143.0500 · High 188.0000
Lifetime High ₹301.9500 (July 4, 2024)
Lifetime Low ₹13.0000 (Jan. 13, 2015)

Full price history and technicals →

Technicals

Full technicals, indicators & Volume/Delivery →

EMA & SMA

Bullish0
Bearish6
5D
152.3
10D
153.7
20D
156.6
50D
173.0
100D
187.8
200D
202.4

Delivery and volume

Day avg. delivery
87.5%
Week avg. delivery
86.4%
Month avg. delivery
95.9%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

151.62
Pivot
First resistance154.88
Second resistance160.77
Third resistance164.03
First support145.73
Second support142.47
Third support136.58
Day RSI37.2
Day MFI85.8
Day MACD-5.78
Day MACD signal-7.43

Beta

1M0.30
3M0.45
1Y0.45
3Y0.64

Price change analysis

↓ -4.5%
Over 1 Month
LowHigh
143.05164.95
↓ -50.0%
Over 3 Months
LowHigh
143.05188.00
↓ -50.0%
Over 6 Months
LowHigh
143.05188.00
↓ -50.0%
Over 1 Year
LowHigh
143.05188.00
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 8.0 (own history: 10.5–21.8)
Undervalued (below its own historical PE range)

Financials

View full financials, peers & valuation multiples →
Revenue (June 30, 2026)
₹7 Cr
Net profit (June 30, 2026)
₹1 Cr
Basic EPS (June 30, 2026)
₹2.0400

Ranks #153 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter61.98%

Largest holders

Data unavailable.

Historical promoter holding

Promoters holdings were unchanged at 61.98% in Jun 2026 qtr

All shareholding details →

Deals (Bulk & Block)

All 19 deals, with filters and CSV →
DateClientDealActionQuantityPriceExchange
21 Aug 2024 MULTIPLIER SHARE & STOCK ADVISORS PRIVATE LIMITED Bulk Buy 15,947 304.7000 BSE
29 May 2024 AMRITA JAIN Bulk Sell 16,592 243.5200 BSE
29 May 2024 AMRITA JAIN Bulk Buy 16,592 242.3800 BSE
29 May 2024 SUMANCHEPURI Bulk Sell 17,096 244.0500 BSE
16 Nov 2022 KETAKI PRIYADARSHAN SIRAS Bulk Buy 17,920 142.2500 BSE
15 Nov 2022 VIJAYKUMAR . Bulk Buy 3,000 137.7500 BSE
15 Nov 2022 VIJAYKUMAR . Bulk Sell 28,364 132.5300 BSE
20 Sep 2021 PRADEEP KUMAR JAIN Bulk Sell 20,310 166.8700 BSE
10 Aug 2021 PCS SECURITIES LIMITED Bulk Buy 20,000 135.4800 BSE
4 Dec 2018 MOHAN LAKSHMI Bulk Buy 19,300 39.9500 BSE

All bulk and block deals →

Corporate Announcements

All 1 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

DateCategoryAnnouncement
30 Sep 2026 Insider Trading / SAST Vasundhara Rasayans Ltd - 538634 - Closure of Trading Window

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Low financial leverage (Debt/Equity 0.04)
  • Comfortable interest coverage (26.3x)

Weaknesses

  • Declining revenue YoY (-8.3%)

Opportunities

  • PEG below 1 (0.22) -- earnings growth outpacing its own valuation
  • PE below 15 (8.0) relative to a typical growth business

Threats

  • Down 50.0% over the past year

Board of directors and corporate information →

F&O

View F&O, Options & Backtest →

Data unavailable (no single-stock futures or options activity on record for this company).

Frequently asked questions about Vasundhara Rasayans Ltd.

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.